Clinical Trials Browser

Phase 3 × Sarcoma × Dexrazoxane × Clear all

NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Phase 3 Completed

Sarcoma, Cardiotoxicity

NCT00334867 2013-06-28

Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma

Phase 3 Withdrawn

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral